lobbying_activities: 1414430

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1414430	fb2d24d2-448b-4887-b6d9-7cc762fa891c	Q2	MEDEXPERT CONSULTING, INC.	401061992	BIOCRYST PHARMACEUTICALS, INC.	2013	second_quarter	MED	Funding for development of medical countermeasures directed against bioterrorism agents that pose a significant threat to public health and national security.	Defense Threat Reduction Agency (DTRA),HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2013-07-18T16:51:46.377000-04:00